Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
07/2003
07/09/2003CN1113895C Growth hormone secretagogues
07/09/2003CN1113862C Arysulfonylamino hydroxamic acid derivs.
07/09/2003CN1113663C Medicinal composition for curing protrusion of lumber intervertebral disc
07/08/2003US6590085 Derivatives of monosaccharides as cell adhesion inhibitors
07/08/2003US6589991 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
07/08/2003US6589979 Derivatives of seco-baccatine III, with bioavailability through the oral route, reduced toxicity and high antiangiogenetic activity; use as antiarthritic agent as well
07/08/2003US6589978 Therapy for nervous system disorders
07/08/2003US6589972 Anticancer agents, osteoporosis, arteriosclerosis, restnosis,vision defects
07/08/2003US6589954 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful
07/08/2003US6589944 A method of cleaving glycation endproducts or cross-linked proteins in an organism in need thereof, wherein said method comprises administering an effective amount of a compound or pharmaceutically acceptable salt thereof to said organism for
07/08/2003US6589503 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
07/03/2003WO2003054208A2 Method of modulating release of saccharides and uses thereof
07/03/2003WO2003054018A2 Anti-tirc7 antibodies in therapy of inflammatory diseases
07/03/2003WO2003054012A2 Leptin proteins
07/03/2003WO2003053977A1 Tetracyclic heterocompounds as estrogen receptor modulators
07/03/2003WO2003053975A1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
07/03/2003WO2003053974A1 Novel compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
07/03/2003WO2003053969A1 Imidazoquinoline derivatives
07/03/2003WO2003053967A1 Aroyl pyridinones
07/03/2003WO2003053957A1 Benzhydryl derivatives
07/03/2003WO2003053955A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases
07/03/2003WO2003053945A2 Urea derivatives and their use as vanilloid receptor antagonists
07/03/2003WO2003053941A2 Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases
07/03/2003WO2003053923A2 Pyrrolidine derivatives as prostaglandin modulators
07/03/2003WO2003053915A2 Compounds for the treatment of inflammatory disorders
07/03/2003WO2003053467A1 Drug for regenerating tissue and vessel and method therefor
07/03/2003WO2003053456A1 Use of hyperforin or st john's wort extracts against anaphylactic states of shock and for maintaining and improving bone health
07/03/2003WO2003053442A1 Tempamine compositions and methods of use
07/03/2003WO2003053368A2 Chalcone derivatives and their use to treat diseases
07/03/2003WO2003053366A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use
07/03/2003WO2003053364A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
07/03/2003WO2003053361A2 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE
07/03/2003WO2003053359A2 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
07/03/2003WO2003053358A2 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
07/03/2003WO2003053354A2 Fused cyclic modulators of nuclear hormone receptor function
07/03/2003WO2003053346A2 Systems and methods for treating patients with processed lipoaspirate cells
07/03/2003WO2003053331A2 Protease inhibitors
07/03/2003WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003WO2003053167A1 Composition for promotion of bone growth and maintenance of bone health
07/03/2003WO2003053166A1 Food or pet food composition containing plant extract for bone health
07/03/2003WO2003053163A2 Salt composition with low sodium chloride and high organic potassium salt content and uses thereof
07/03/2003WO2003030823A3 Combinations for the treatment of immunoinflammatory disorders
07/03/2003WO2003013440A3 Treatment and prevention of heat shock protein-associated diseases and conditions
07/03/2003WO2002084249A3 Therapeutic and diagnostic uses of antibody specificity profiles
07/03/2003WO2002070657A3 93870, a human g-protein coupled receptor and uses therefor
07/03/2003WO2002028481A9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
07/03/2003US20030125565 2,5-dioxoimidazolidine or 2-thio-5-oxoimidazolidine derivatives suitable for the therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorder
07/03/2003US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor
07/03/2003US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis
07/03/2003US20030125360 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
07/03/2003US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/03/2003US20030125344 Rho-kinase inhibitors
07/03/2003US20030125342 6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents
07/03/2003US20030125309 Cyclic ether vitamin D3 compounds, 1alpha(OH) 3-epi- vitamin D3 compounds and uses thereof
07/03/2003US20030125299 Method for treating or preventing inflammatory diseases
07/03/2003US20030125290 Cancer treatment with a synthetic sequences
07/03/2003US20030125259 Administering to the mammal a therapeutically acceptable amount of a octa or nonapeptide compound to inhibit the angiogenesis
07/03/2003US20030125252 Administering to a vertebrate an effective osteogenesis stimulating amount of an RAR (retinoic acid receptor) antagonist to treat both metabolic or non-metabolic diseases; RAR antisense oligonucleotide
07/03/2003US20030125248 Novel bone mineralization proteins, DNA, vectors expression systems
07/03/2003US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein
07/03/2003US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment
07/03/2003US20030124723 Use of a nuclease inhibitor or interleukin-10 (IL-10) for the preparation of a therapeutic composition for improving transfection of a polynucleotide into a cell and compositions useful in gene therapy
07/03/2003US20030124617 Antiinflammatory agents; antiarthritic agents; interleukins; antiallergens; bronchodilator agents
07/03/2003US20030124529 Pregnancy-associated plasma protein-A2 (PAPP-A2)
07/03/2003US20030124219 Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals
07/03/2003US20030124196 Pulsatile release compositions and methods for enhanced intestinal drug absorption
07/03/2003US20030124129 Angiopoietin-2 specific binding agents
07/03/2003US20030124121 Treating septic arthritis
07/03/2003US20030124110 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases
07/03/2003CA2849201A1 Adipose-derived cell processing unit
07/03/2003CA2507870A1 Method of modulating release of saccharides and uses thereof
07/03/2003CA2486930A1 Anti-tirc7 antibodies in therapy of inflammatory diseases
07/03/2003CA2471107A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
07/03/2003CA2471085A1 Aroyl pyridinones
07/03/2003CA2471083A1 Benzhydryl derivatives
07/03/2003CA2470931A1 Chalcone derivatives and their use to treat diseases
07/03/2003CA2470594A1 Leptin proteins
07/03/2003CA2470576A1 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003CA2470063A1 Parmaceutical agents and methods for tissue and vascular regeneration
07/03/2003CA2469551A1 Composition for promotion of bone growth and maintenance of bone health
07/03/2003CA2469370A1 Adipose-derived cell processing unit
07/03/2003CA2469047A1 Tempamine compositions and methods of use
07/03/2003CA2466617A1 Food or pet food composition containing plant extract for bone health
07/03/2003CA2448811A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases
07/03/2003CA2436850A1 Protease inhibitors
07/02/2003EP1323711A1 Novel phenylalanine derivatives
07/02/2003EP1322769A2 Protein phosphatases
07/02/2003EP1322760A2 G-protein coupled receptors
07/02/2003EP1322755A1 Human and mouse targeting peptides identified by phage display
07/02/2003EP1322752A2 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof
07/02/2003EP1322647A1 Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt and process for their preparation
07/02/2003EP1322642A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES
07/02/2003EP1322641A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases
07/02/2003EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives
07/02/2003EP1322623A2 Hydroxy acid integrin antagonists
07/02/2003EP1322617A1 Compounds and methods for modulation of estrogen receptors
07/02/2003EP1322616A2 Quinoline-(c=o)-(di-, tri- and tetrapeptide) derivatives as caspase inhibitors
07/02/2003EP1322613A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
07/02/2003EP1322598A1 Nitroso diphenylamine derivatives
07/02/2003EP1322383A2 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
1 ... 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 ... 820